<DOC>
	<DOCNO>NCT00150449</DOCNO>
	<brief_summary>Determine long-term safety tolerability pregabalin patient anxiety disorder .</brief_summary>
	<brief_title>Determine Long-Term Safety Tolerability Pregabalin Patients With Anxiety Disorders .</brief_title>
	<detailed_description />
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Must complete doubleblind portion precede trial Completed protocol specify withdrawal phase followup visit . Patient participate experience serious adverse event nonserious , medically significant adverse event precede efficacy study judge related study medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2006</verification_date>
</DOC>